Canada markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
154.33+3.11 (+2.06%)
At close: 04:00PM EDT
154.33 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 19.13B
Enterprise Value 18.06B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.47
Price/Book (mrq)N/A
Enterprise Value/Revenue 9.02
Enterprise Value/EBITDA -179.20

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3-27.24%
S&P500 52-Week Change 325.77%
52 Week High 3218.88
52 Week Low 3141.98
50-Day Moving Average 3149.69
200-Day Moving Average 3171.14

Share Statistics

Avg Vol (3 month) 3814.27k
Avg Vol (10 day) 3496.22k
Shares Outstanding 5126.49M
Implied Shares Outstanding 6126.49M
Float 8125.95M
% Held by Insiders 10.41%
% Held by Institutions 194.30%
Shares Short (Apr 15, 2024) 42.5M
Short Ratio (Apr 15, 2024) 44.49
Short % of Float (Apr 15, 2024) 42.28%
Short % of Shares Outstanding (Apr 15, 2024) 41.98%
Shares Short (prior month Mar 15, 2024) 42.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -16.58%
Operating Margin (ttm)-8.79%

Management Effectiveness

Return on Assets (ttm)-3.05%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2B
Revenue Per Share (ttm)15.97
Quarterly Revenue Growth (yoy)54.80%
Gross Profit (ttm)N/A
EBITDA -122.3M
Net Income Avi to Common (ttm)-332.08M
Diluted EPS (ttm)-2.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.37B
Total Cash Per Share (mrq)18.75
Total Debt (mrq)2.68B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.17
Book Value Per Share (mrq)-1.73

Cash Flow Statement

Operating Cash Flow (ttm)189.12M
Levered Free Cash Flow (ttm)172.9M